Diagnosis and Management of Adrenocortical Carcinoma with co-secretion of Cortisol and Aldosterone
A Case Report
DOI:
https://doi.org/10.15605/jafes.039.02.13Keywords:
adrenocortical carcinoma, primary hyperaldosteronism, Cushing’s syndrome, aldosteroneAbstract
Adrenocortical carcinoma (ACC) accounts for 0.05-2% of all malignant tumors. Forty-five percent of ACCs with secretory function have excess glucocorticoids alone and only less than 1% secrete aldosterone.
This is a case of a 44-year-old Filipino female with hypertension and a 12-year-history of an incidentaloma of the left adrenal gland, with recent-onset complaints of increasing abdominal girth, purple striae, amenorrhea, moon facies and a dorsocervical fat pad. Laboratory findings revealed low potassium levels, non-suppressed cortisol on dexamethasone test suggesting Cushing’s syndrome and elevated aldosterone-renin ratio and plasma aldosterone concentration pointing to primary hyperaldosteronism. A computed tomography scan revealed a left-sided adrenal mass measuring approximately 23 cm in largest diameter suggestive of carcinoma without metastasis or lymph node involvement. Complete resection via open adrenalectomy was performed and histopathologic assessment revealed Adrenocortical Carcinoma with Weiss score of 4. The Ki-67 proliferative index was found to be >20%. Radiotherapy was done as an adjuvant treatment.
Although rare, co-secretion of cortisol and aldosterone can occur in functional tumors of adrenocortical carcinoma. Malignancy should always be considered in patients who present with a history of a unilateral adrenal mass and/ or in those with signs and symptoms of adrenal hormone excess. Thus, a proper assessment derived from a thorough medical history, physical examination and laboratory work-up is warranted in patients with an adrenal mass to ascertain the diagnosis and provide adequate management.
Downloads
References
1. Nakamura Y, Yamazaki Y, Felizola SJ, et al. Adrenocortical carcinoma.: Review of the pathologic features, production of adrenal steroids, and molecular pathogenesis. Endocrinology and Metabolism Clinics of North America. 2015;44(2):399–410. https://doi.org/10.1016/j.ecl.2015.02.007
2. Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine, 21st ed. New York: McGraw Hill Education; 2021.
3. Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ. Williams textbook of endocrinology, 14th ed. Philadelphia: Elsevier; 2020.
4. Libé R, Huillard O. Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease. Cancer Treat Res Commun. 2023;37:100759. https://pubmed.ncbi.nlm.nih.gov/37690343 https://doi.org/10.1016/j.ctarc.2023.100759
5. Wagner-Bartak NA, Baiomy A, Habra MA, et al. Cushing syndrome: Diagnostic workup and imaging features, with clinical and pathologic correlation. Am J Roentgenol. 2017;209(1):19–32. https://pubmed.ncbi.nlm.nih.gov/28639924 https://doi.org/10.2214/AJR.16.17290
6. Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889–916. https://pubmed.ncbi.nlm.nih.gov/26934393 https://doi.org/ 10.1210/jc.2015-4061
7. Rossi GP, Auchus RJ, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63(1):151–60. https://pubmed.ncbi.nlm.nih.gov/24218436 https://doi.org/10.1161/HYPERTENSIONAHA.113.02097
8. He X, Peter PR, Auchus RJ. Approach to the patient with an incidental adrenal mass. Med Clin North Am. 2021;105(6):1047-63. https://pubmed.ncbi.nlm.nih.gov/34688414 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984966 https://doi.org/10.1016/j.mcna.2021.06.009
9. Fassnacht M, Dekkers OM, Else T. et al. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2018;179(4):G1-46. https://pubmed.ncbi.nlm.nih.gov/30299884 https://doi.org/10.1530/EJE-18-0608
10. Kiseljak-Vassiliades K, Bancos I, Hamrahian A, et al. American Association of Clinical Endocrinology Disease State Clinical Review on the evaluation and management of adrenocortical carcinoma in an adult: a practical approach. Endocr Pract. 2020;26(11):1366-83. https://pubmed.ncbi.nlm.nih.gov/33875173 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058447 https://doi.org/10.4158/DSCR-2020-0567
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Meghan Marie Aliño, Lyzanne Maryl Tam-Go
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.
